Dennis L. Sprecher

11.7k total citations
150 papers, 7.6k citations indexed

About

Dennis L. Sprecher is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Dennis L. Sprecher has authored 150 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Surgery, 50 papers in Endocrinology, Diabetes and Metabolism and 41 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Dennis L. Sprecher's work include Lipoproteins and Cardiovascular Health (56 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (39 papers) and Obesity, Physical Activity, Diet (15 papers). Dennis L. Sprecher is often cited by papers focused on Lipoproteins and Cardiovascular Health (56 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (39 papers) and Obesity, Physical Activity, Diet (15 papers). Dennis L. Sprecher collaborates with scholars based in United States, United Kingdom and Canada. Dennis L. Sprecher's co-authors include Gregory L. Pearce, John A. Morrison, Stephen R. Daniels, Philip R. Khoury, Bruce Barton, Stanley L. Hazen, Marc S. Penn, Mehdi H. Shishehbor, Ronnier J. Aviles and Xiaoming Fu and has published in prestigious journals such as The Lancet, JAMA and Journal of Biological Chemistry.

In The Last Decade

Dennis L. Sprecher

148 papers receiving 7.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dennis L. Sprecher United States	46	2.5k	1.9k	1.9k	1.4k	1.0k	150	7.6k
Alberto Zambon Italy	33	1.8k 0.7×	2.3k 1.2×	1.5k 0.8×	828 0.6×	613 0.6×	90	5.9k
L. Masana Spain	49	4.6k 1.8×	3.0k 1.6×	2.4k 1.3×	2.2k 1.6×	469 0.5×	376	10.0k
Barry I. Freedman United States	65	1.8k 0.7×	3.2k 1.6×	2.6k 1.4×	3.3k 2.3×	822 0.8×	420	16.3k
Mikko Niemi Finland	64	3.2k 1.3×	1.8k 1.0×	1.0k 0.6×	2.5k 1.8×	702 0.7×	277	15.2k
William R. Hazzard United States	52	4.3k 1.7×	4.9k 2.5×	2.2k 1.2×	1.6k 1.2×	673 0.7×	151	11.2k
John D. Brunzell United States	59	3.7k 1.5×	6.2k 3.2×	3.1k 1.7×	1.7k 1.2×	955 0.9×	147	11.5k
Nehal N. Mehta United States	57	1.4k 0.6×	1.1k 0.6×	1.6k 0.9×	2.2k 1.6×	493 0.5×	268	12.2k
Judith Hsia United States	48	2.8k 1.1×	4.6k 2.4×	3.5k 1.9×	932 0.7×	1.2k 1.2×	150	11.9k
Lars Berglund United States	59	4.7k 1.9×	3.3k 1.7×	2.2k 1.2×	2.7k 1.9×	798 0.8×	249	12.7k
Francisco Antônio Helfenstein Fonseca Brazil	29	6.2k 2.5×	2.5k 1.3×	3.4k 1.8×	1.4k 1.0×	701 0.7×	154	11.7k

Countries citing papers authored by Dennis L. Sprecher

Since Specialization

Citations

This map shows the geographic impact of Dennis L. Sprecher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis L. Sprecher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis L. Sprecher more than expected).

Fields of papers citing papers by Dennis L. Sprecher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis L. Sprecher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis L. Sprecher. The network helps show where Dennis L. Sprecher may publish in the future.

Co-authorship network of co-authors of Dennis L. Sprecher

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis L. Sprecher. A scholar is included among the top collaborators of Dennis L. Sprecher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis L. Sprecher. Dennis L. Sprecher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stewart, Glenn M., Bruce D. Johnson, Dennis L. Sprecher, et al.. (2020). Targeting Pulmonary Capillary Permeability to Reduce Lung Congestion in Heart Failure: A Randomized, Controlled Pilot Trial. European Journal of Heart Failure. 22(9). 1641–1645. 32 indexed citations

Sprecher, Dennis L., et al.. (2015). Discovery and characterization of GSK256073, a non-flushing hydroxy-carboxylic acid receptor 2 (HCA2) agonist. European Journal of Pharmacology. 756. 1–7. 21 indexed citations

Olson, Eric J., Gregory L. Pearce, Nigel C. Jones, & Dennis L. Sprecher. (2012). Lipid Effects of Peroxisome Proliferator-Activated Receptor-Δ Agonist GW501516 in Subjects With Low High-Density Lipoprotein Cholesterol. Arteriosclerosis Thrombosis and Vascular Biology. 32(9). 2289–2294. 59 indexed citations

Ooi, Esther, Gerald F. Watts, Dennis L. Sprecher, Dick C. Chan, & P. Hugh R. Barrett. (2011). Mechanism of Action of a Peroxisome Proliferator-Activated Receptor (PPAR)-δ Agonist on Lipoprotein Metabolism in Dyslipidemic Subjects with Central Obesity. The Journal of Clinical Endocrinology & Metabolism. 96(10). E1568–E1576. 64 indexed citations

Elkhawad, Maysoon, Lea Sarov‐Blat, Michael Marber, et al.. (2010). Inhibition of p38 Mitogen-Activated Protein Kinase Attenuates Vascular and Systemic Inflammation in Patients with Atherosclerosis as Assessed by 18-F Fluorodeoxyglucose PET-CT. Circulation. 122(4). 211–20. 3 indexed citations

Nichols, Gregory A., et al.. (2006). The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: A retrospective chart review involving up to 8 years of follow-up. Clinical Therapeutics. 28(2). 243–250. 6 indexed citations

Shishehbor, Mehdi H., Ronnier J. Aviles, Marie‐Luise Brennan, et al.. (2003). Levels of nitrotyrosine, an inflammatory marker generated by nitric oxide derived oxidants, is associated with risk of coronary artery disease. Journal of the American College of Cardiology. 41(6). 303–303. 4 indexed citations

Sprecher, Dennis L., et al.. (2001). A Novel Test for the Measurement of Skin Cholesterol. Clinical Chemistry. 47(7). 1302–1304. 20 indexed citations

Blackburn, Gordon, JoAnne M. Foody, Dennis L. Sprecher, et al.. (2000). Cardiac Rehabilitation Participation Patterns in a Large, Tertiary Care Center: Evidence for Selection Bias. Journal of Cardiopulmonary Rehabilitation. 20(3). 189–195. 77 indexed citations

10.

Salomon, Robert G., Kamaljit Kaur, Dennis L. Sprecher, et al.. (2000). Isolevuglandin–protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1485(2-3). 225–235. 67 indexed citations

11.

Mayer, Kenneth H., Michael P. Dubé, Dennis L. Sprecher, et al.. (2000). Preliminary Guidelines for the Evaluation and Management of Dyslipidemia in Adults Infected with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group. Clinical Infectious Diseases. 31(5). 1216–1224. 166 indexed citations

12.

Foody, JoAnne M., John Milberg, Gregory L. Pearce, & Dennis L. Sprecher. (2000). Lipoprotein(a) associated with coronary artery disease in older women: age and gender analysis. Atherosclerosis. 153(2). 445–451. 24 indexed citations

13.

Sprecher, Dennis L., et al.. (1996). Higher Triglycerides, Lower High-Density Lipoprotein Cholesterol, and Higher Systolic Blood Pressure in Lipoprotein Lipase–Deficient Heterozygotes. Circulation. 94(12). 3239–3245. 25 indexed citations

14.

Morrison, John A., Bruce Barton, Frank M. Biro, et al.. (1994). Sexual maturation and obesity in 9- and 10-year-old black and white girls: The National Heart, Lung, and Blood Institute Growth and Health Study. The Journal of Pediatrics. 124(6). 889–895. 115 indexed citations

15.

Gotto, Antonio M., William J. Breen, Clinton N. Corder, et al.. (1993). Once-daily, extended-release gemfibrozil in patients with dyslipidemia. The American Journal of Cardiology. 71(12). 1057–1063. 10 indexed citations

16.

Sprecher, Dennis L., D Black, L. Kaplan, et al.. (1991). Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families.. Journal of Clinical Investigation. 88(3). 985–994. 47 indexed citations

17.

Yamashita, Shizuya, Dennis L. Sprecher, Naohiko Sakai, et al.. (1990). Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency.. Journal of Clinical Investigation. 86(3). 688–695. 150 indexed citations

18.

Sprecher, Dennis L., Eileen M. Mikat, Richard S. Stack, et al.. (1989). Histopathologic examination of material from angioplasty balloon catheters used in vivo in human coronary arteries. Atherosclerosis. 75(2-3). 237–244. 1 indexed citations

19.

Manzato, Enzo, Carlo Gabelli, R. Fellin, et al.. (1986). Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.. Journal of Clinical Investigation. 77(2). 520–527. 92 indexed citations

20.

Brewer, H. Bryan, Dennis L. Sprecher, Richard E. Gregg, & Jeffrey M. Hoeg. (1985). Risk Factors for the Development of Premature Cardiovascular Disease. PubMed. 183. 27–36. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact